Suppr超能文献

临床前阿尔茨海默病中的淡漠:淡漠评估量表的心理测量学验证。

Apathy in Preclinical Alzheimer's Disease: Psychometric Validation of the Apathy Evaluation Scale.

机构信息

1 Department of Rehabilitation Sciences, University of Texas at El Paso, El Paso, TX, USA.

2 Geriatric Research, Education and Clinical Center, W. S. Middleton Memorial Veterans Hospital, Madison, WI, USA.

出版信息

Am J Alzheimers Dis Other Demen. 2019 Feb;34(1):16-22. doi: 10.1177/1533317518794020. Epub 2018 Aug 14.

Abstract

OBJECTIVES

The purpose of the present study was to validate the Apathy Evaluation Scale, self-rated version (AES-S), and assess the severity of apathy in a cognitively healthy middle-aged cohort at risk for Alzheimer's disease (AD).

METHOD

Three hundred and sixteen middle-aged adults were selected to represent a subset of the Wisconsin Alzheimer's Disease Research Center Clinical Core: the Investigating Memory in People At-risk, Causes and Treatments cohort.

RESULTS

An exploratory factor analysis (EFA) with varimax rotation identified 3 subscales: apathy, disinterest, and social withdrawal factors. Confirmatory factor analysis confirmed the EFA findings. Results indicated acceptable convergent and discriminant validity. The AES-S is a reliable instrument to quantify apathy in cognitively healthy middle-aged individuals at risk for AD.

DISCUSSION

This study demonstrates the AES-S is a psychometrically sound measurement tool for assessing levels of apathy in a cognitively healthy middle-aged cohort at risk for AD.

摘要

目的

本研究旨在验证自评版淡漠评估量表(AES-S),并评估认知健康的中年阿尔茨海默病(AD)高危人群的淡漠严重程度。

方法

从威斯康星州阿尔茨海默病研究中心临床核心的“有记忆障碍风险人群的病因和治疗研究”队列中选取了 316 名中年成年人作为研究对象。

结果

采用方差极大旋转的探索性因子分析(EFA)确定了 3 个亚量表:淡漠、兴趣缺失和社会退缩因子。验证性因子分析证实了 EFA 的结果。研究结果表明该量表具有可接受的聚合效度和区分效度。AES-S 是一种可靠的工具,可用于量化认知健康的中年 AD 高危人群的淡漠程度。

讨论

本研究表明,AES-S 是一种用于评估认知健康的中年 AD 高危人群淡漠程度的具有良好心理测量学特性的测量工具。

相似文献

1
Apathy in Preclinical Alzheimer's Disease: Psychometric Validation of the Apathy Evaluation Scale.
Am J Alzheimers Dis Other Demen. 2019 Feb;34(1):16-22. doi: 10.1177/1533317518794020. Epub 2018 Aug 14.
2
A Novel Assessment and Profiling of Multidimensional Apathy in Alzheimer's Disease.
J Alzheimers Dis. 2017;60(1):57-67. doi: 10.3233/JAD-170292.
5
Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer's disease.
Psychiatry Clin Neurosci. 2012 Apr;66(3):227-34. doi: 10.1111/j.1440-1819.2011.02315.x.
6
Assessing apathy in multiple sclerosis: Validation of the dimensional apathy scale and comparison with apathy evaluation scale.
Mult Scler Relat Disord. 2020 Feb;38:101870. doi: 10.1016/j.msard.2019.101870. Epub 2019 Nov 25.
7
Clinical utility and psychometric properties of the Apathy Evaluation Scale.
Rehabil Psychol. 2020 Aug;65(3):311-312. doi: 10.1037/rep0000356.
8
Apathy in multiple sclerosis: a validation study of the apathy evaluation scale.
J Neurol Sci. 2014 Dec 15;347(1-2):295-300. doi: 10.1016/j.jns.2014.10.027. Epub 2014 Oct 23.
9
Assessment of apathy independent of physical disability: validation of the Dimensional Apathy Scale in Italian healthy sample.
Neurol Sci. 2017 Feb;38(2):303-309. doi: 10.1007/s10072-016-2766-8. Epub 2016 Nov 14.

引用本文的文献

1
2
The neural basis of neuropsychiatric symptoms in Alzheimer's disease.
Front Aging Neurosci. 2024 Dec 5;16:1487875. doi: 10.3389/fnagi.2024.1487875. eCollection 2024.
3
Study Partner Report of Apathy in Older Adults is Associated with AD Biomarkers: Findings from the Harvard Aging Brain Study.
Am J Geriatr Psychiatry. 2024 Aug;32(8):909-919. doi: 10.1016/j.jagp.2024.01.020. Epub 2024 Jan 28.
6
Creative Art Therapy as a Non-Pharmacological Intervention for Dementia: A Systematic Review.
J Alzheimers Dis Rep. 2021 May 3;5(1):353-364. doi: 10.3233/ADR-201002.
7
Multidimensional Apathy: The Utility of the Dimensional Apathy Scale in Huntington's Disease.
Mov Disord Clin Pract. 2021 Feb 12;8(3):361-370. doi: 10.1002/mdc3.13147. eCollection 2021 Apr.
8
Clinical utility and psychometric properties of the Apathy Evaluation Scale.
Rehabil Psychol. 2020 Aug;65(3):311-312. doi: 10.1037/rep0000356.
9
The implications of different approaches to define AT(N) in Alzheimer disease.
Neurology. 2020 May 26;94(21):e2233-e2244. doi: 10.1212/WNL.0000000000009485. Epub 2020 May 12.

本文引用的文献

1
Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States.
Alzheimers Dement. 2018 Feb;14(2):121-129. doi: 10.1016/j.jalz.2017.10.009. Epub 2017 Dec 7.
2
Distinct Subtypes of Apathy Revealed by the Apathy Motivation Index.
PLoS One. 2017 Jan 11;12(1):e0169938. doi: 10.1371/journal.pone.0169938. eCollection 2017.
4
Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels.
Am J Geriatr Psychiatry. 2016 Nov;24(11):1095-1104. doi: 10.1016/j.jagp.2016.04.004. Epub 2016 Apr 19.
5
Patterns and persistence of behavioural and psychological symptoms in those with cognitive impairment: the importance of apathy.
Int J Geriatr Psychiatry. 2017 Mar;32(3):306-315. doi: 10.1002/gps.4464. Epub 2016 Mar 27.
7
Apathy in multiple sclerosis: a validation study of the apathy evaluation scale.
J Neurol Sci. 2014 Dec 15;347(1-2):295-300. doi: 10.1016/j.jns.2014.10.027. Epub 2014 Oct 23.
8
Developing a new apathy measurement scale: Dimensional Apathy Scale.
Psychiatry Res. 2014 Nov 30;219(3):658-63. doi: 10.1016/j.psychres.2014.06.010. Epub 2014 Jun 19.
9
Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study.
Int J Geriatr Psychiatry. 2015 May;30(5):470-7. doi: 10.1002/gps.4161. Epub 2014 Jun 20.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验